Literature DB >> 21109762

COMP-Ang1, a variant of angiopoietin 1, inhibits serum-deprived apoptosis of mesenchymal cells via PI3K/Akt and mitogen-activated protein kinase pathways.

Kkot-Nim Lee1, Min-Chul Seo, In-Ho Bae, Sin-Hye Oh, Won Gu Jang, Byung-Chul Jeong, Won-Mann Oh, Sun-Hun Kim, Shee-Eun Lee, Kyung Mi Shim, Bae-Keun Park, Jeong-Tae Koh.   

Abstract

BACKGROUND/AIMS: Cartilage oligomeric matrix protein (COMP)-angiopoietin 1 (Ang1) is a soluble and stable form of Ang1 which plays important roles in vessel formation and the survival of endothelial cells, neurons and cardiomyocytes. However, the effects of COMP-Ang1 on the survival of mesenchymal cells are unknown. Mesenchymal cells have been transplanted with some scaffolds for bone tissue regeneration, but they occasionally underwent cell death due to a lack of nutrient supply. This study examined the effects of COMP-Ang1 on the survival of mesenchymal cells under nutrient-deprived conditions.
METHODS: Primary and C3H10T1/2 mesenchymal cells were cultured under serum deprivation with or without COMP-Ang1. The effects of COMP-Ang1 on mesenchymal cell survival and its molecular mechanism were determined using a viability test, RT-PCR, Western blotting and fluorescence-activated cell sorting analysis. RESULTS AND
CONCLUSION: COMP-Ang1 inhibited the nutrient-deprived apoptotic cell death of mesenchymal cells through the Akt, p38 and extracellular-signal-regulated kinase (ERK) pathways. In addition, COMP-Ang1 reversed the nutrient-deprived suppression of cyclin D1 mRNA expression. These results suggest that COMP-Ang1 has a protective role in the survival of nutrient-deprived mesenchymal cells. The use of COMP-Ang1 with some scaffolds might be useful for bone tissue engineering.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21109762     DOI: 10.1159/000321885

Source DB:  PubMed          Journal:  Pharmacology        ISSN: 0031-7012            Impact factor:   2.547


  4 in total

1.  Shikonin inhibits inflammation and chondrocyte apoptosis by regulation of the PI3K/Akt signaling pathway in a rat model of osteoarthritis.

Authors:  Daijie Fu; Xifu Shang; Zhe Ni; Guoguang Shi
Journal:  Exp Ther Med       Date:  2016-08-31       Impact factor: 2.447

2.  COMP-angiopoietin-1 recovers molecular biomarkers of neuropathy and improves vascularisation in sciatic nerve of ob/ob mice.

Authors:  Joanna Kosacka; Marcin Nowicki; Nora Klöting; Matthias Kern; Michael Stumvoll; Ingo Bechmann; Heike Serke; Matthias Blüher
Journal:  PLoS One       Date:  2012-03-06       Impact factor: 3.240

3.  The Angiopoietin-1 Variant COMP-Ang1 Enhances BMP2-Induced Bone Regeneration with Recruiting Pericytes in Critical Sized Calvarial Defects.

Authors:  Hyuck Choi; Byung-Chul Jeong; Sung-Woong Hur; Jung-Woo Kim; Keun-Bae Lee; Jeong-Tae Koh
Journal:  PLoS One       Date:  2015-10-14       Impact factor: 3.240

4.  Cartilage Oligomeric Matrix Protein promotes epithelial-mesenchymal transition by interacting with Transgelin in Colorectal Cancer.

Authors:  Weilong Zhong; Huiqin Hou; Tianyu Liu; Shuai Su; Xiaonan Xi; Yusheng Liao; Runxiang Xie; Ge Jin; Xiang Liu; Lanping Zhu; Hongxia Zhang; Xueli Song; Cheng Yang; Tao Sun; Hailong Cao; Bangmao Wang
Journal:  Theranostics       Date:  2020-07-09       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.